Summary

Eligibility
for people ages 2-17 (full criteria)
Location
at UCSF
Dates
study started
completion around

Description

Summary

The purpose of this study is to determine the safety profile of long-term vedolizumab IV treatment in pediatric participants with UC or CD.

Official Title

A Phase 2b, Extension Study to Determine the Long-term Safety of Vedolizumab IV in Pediatric Subjects With Ulcerative Colitis or Crohn's Disease

Details

Keywords

Ulcerative Colitis, Crohn's Disease, Drug Therapy, Colitis, Crohn Disease, Ulcer, Vedolizumab

Eligibility

Locations

  • University of California San Francisco
    San Francisco California 94158 United States
  • Cedars-Sinai Medical Center
    Los Angeles California 90048 United States
  • Children's Hospital of Orange County
    Orange California 92868 United States

Details

Status
in progress, not accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Takeda
ID
NCT03196427
Phase
Phase 2 research study
Study Type
Interventional
Participants
About 59 people participating
Last Updated